Article Information
History
- November 9, 2021.
Article Versions
- Version 1 (October 22, 2021 - 09:23).
- Version 2 (November 3, 2021 - 10:49).
- Version 3 (November 5, 2021 - 09:01).
- Version 4 (November 6, 2021 - 09:07).
- You are currently viewing Version 5 of this article (November 9, 2021 - 10:56).
- Version 6 (January 26, 2022 - 08:54).
- Version 7 (January 28, 2022 - 11:32).
- View Version 8, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Melina A. Markkanen1,#,
- Kaisa Haukka1,6,
- Katariina M. M. Pärnänen1,
- Victorien Tamegnon Dougnon2,
- Isidore Juste O. Bonkoungou3,
- Zakaria Garba4,
- Halidou Tinto4,
- Anniina Sarekoski1,
- Antti Karkman1,
- Anu Kantele5,6,† and
- Marko P. J. Virta1,*,†
- 1Department of Microbiology, University of Helsinki, Finland
- 2Research Unit in Applied Microbiology and Pharmacology of Natural Substances, Polytechnic School of Abomey-Calavi, University of Abomey-Calavi, Benin
- 3Department of Biochemistry and Microbiology, University Joseph KI-ZERBO, Ouagadougou, Burkina Faso
- 4Clinical Research Unit Nanoro, Institute for Research in Health Sciences, National Center for Scientific and Technological Research, Burkina Faso
- 5Meilahti Infectious Diseases and Vaccine Research Center, MeiVac, Department of Infectious Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- 6Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- ↵#Melina A. Markkanen, melina.markkanen{at}helsinki.fi
↵† Equal contribution